The U.S. now has an approved pediatric drug to prevent respiratory syncytial virus lower respiratory tract disease, which infects nearly every child before they turn 2 years old.
Read the full post on Becker's Hospital Review - Healthcare News
FDA approves 1st RSV drug for babies, toddlers
